------------------------------------------------------------------------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 18, 2004 (May 18, 2004)
Altair Nanotechnologies Inc.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Canada 1-12497 33-1084375
----------------------- --------------------- ---------------------
(State or other (Commission File No.) IRS Employer
jurisdiction Identification No.)
of incorporation)
204 Edison Way
Reno, Nevada 89502
----------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: (775) 858-3750
-------------------------------------------------
(Former Name, if Changed Since Last Report)
===============================================================================
Item 12. Results of Operations and Financial Condition.
Altair Nanotechnologies Inc. ("Altair') has issued a press release entitled
"Altair Nanotechnologies Clarifies Avireco Development Progress." The full text
of the press release is set forth herein beginning on the following page.
2
ALTAIR NANOTECHNOLOGIES CLAIRFIES
AVIRECO DEVELOPMENT PROGRESS
RENO, NV - May 18, 2004 - Altair Nanotechnologies, Inc. (Nasdaq:ALTI) a company
engaged in developing nanomaterials, titanium dioxide pigment technology, and
materials science focused on nanostructures, is clarifying the status of its
testing and development agreement with Avireco, located in Vietnam. Altair has
entered into a testing agreement with Avireco and has been informed that
$250,000 in funds have been budgeted by the government of Vietnam to begin the
first phase of pilot plant testing; however, Altair has not yet received funding
and, as a result, has not commenced any testing work under the agreement.
ALTAIR NANOTECHNOLOGIES, INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair
Nanotechnologies is positioning itself through product innovation within this
emerging industry to become a leading supplier of nanomaterial technology and
nanomaterials worldwide. Altair owns a proprietary technology for making
nanocrystalline materials of unique quality both economically and in large
quantities. The company is currently developing special materials with potential
applications in pharmaceuticals, titanium pigment and metal, batteries, fuel
cells, solar cells, advanced energy storage devices, thermal spray coatings,
catalysts, cosmetics and environmental remediation. For additional information
on Altair and its nanoparticle materials, visit www.altairnano.com.
Forward-Looking Statements
This release may contain forward-looking statements as well as historical
information. Forward- looking statements, which are included in accordance with
the "safe harbor" provisions of the Private Securities Litigation Reform Act of
1995, may involve risks, uncertainties and other factors that may cause the
company's actual results and performance in future periods to be materially
different from any future results or performance suggested by the
forward-looking statements in this release. These risks and uncertainties
include, without limitation, the risks that Altair may never receive significant
revenue from any existing or future agreements with Avireco for various reasons,
including the possibilities that testing may never commence because of a lack of
funding, the results of testing may not be positive and, even if the results are
positive, a full-scale plant may not be designed or constructed. In addition,
other risks are identified in the company's most recent Annual Report on Form
10-K, as filed with the SEC. Such forward-looking statements speak only as of
the date of this release. The company expressly disclaims any obligation to
update or revise any forward-looking statements found herein to reflect any
changes in company expectations or results or any change in events.
# # # #
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this Current Report on Form 8-K to be signed on
its behalf by the undersigned thereunto duly authorized.
Altair Nanotechnologies Inc.
May 18, 2004 By: /s/ Rudi E. Moerck
----------------------- -----------------------------------------
Date Rudi E. Moerck, President
4